SVA Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
SVA Wealth Management's BIIB Position: Q2 2019 in Review
SVA Wealth Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 1,336 shares — an estimated $316K sold.
SVA Wealth Management first reported a position in BIIB in Q4 2013 and held it in 22 quarters. The position peaked at $2.29M in Q3 2016. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.
- SVA Wealth Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
- SVA Wealth Management sold 1,336 Biogen shares in Q2 2019, an estimated $316K.
- SVA Wealth Management first reported a position in Biogen in Q4 2013 and held it in 22 quarters.
- SVA Wealth Management's Biogen position peaked at $2.29M in Q3 2016.
- 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.
Based on SVA Wealth Management's 13F filing for Q2 2019, filed 13 Aug 2019.